Sign in

CIK 0001641281

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Bolt Biotherapeutics, Inc.

Sign in to watch
Ticker
BOLT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472804636
Phone
+1 650-665-9295
Business address
900 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
Former names
Bolt Therapeutics, Inc.
Open-market buys, last 90 days
$628,922
in 2 filings
Open-market sales, last 90 days
$128,281
in 3 filings

Net +$500,641. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-06-12 SHAH MAHENDRA Director Grant or award · Stock Option (Right to Buy) +22,000 22,000
2023-06-12 SHAH MAHENDRA Director Grant or award · Stock Option (Right to Buy) +25,000 25,000
2022-06-10 SHAH MAHENDRA Director Grant or award · Stock Option (Right to Buy) +25,000 25,000
2022-03-24 SHAH MAHENDRA Director Grant or award · Stock Option (Right to Buy) +25,000 25,000
2021-02-09 SHAH MAHENDRA Director Conversion +944,056 958,341
2021-02-09 SHAH MAHENDRA Director Conversion +472,296 1,430,637
2021-02-09 SHAH MAHENDRA Director Option exercise +17,711 $0.07 $1K 1,448,348
2021-02-09 SHAH MAHENDRA Director Sale −62 $20.00 $1K 1,448,286
2021-02-09 SHAH MAHENDRA Director Conversion · Series A- 1 Preferred Stock −944,056 0
2021-02-09 SHAH MAHENDRA Director Conversion · Series B Preferred Stock −472,296 0
2021-02-09 SHAH MAHENDRA Director Option exercise · Warrant (Right to Buy) −17,711 0

Page 1 of 1 · 11 trades